Astec Lifesciences has informed that the Board of Directors of the Company, at its Meeting held on Friday, 28th October, 2022, has approved the Unaudited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2022. It enclosed a copy of the Press Release and the same is being placed on the website of the Company, www.astecls.com
The above information is a part of company’s filings submitted to BSE.